Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

SHE:002693 Revenue

Hainan Shuangcheng Pharmaceuticals had revenue of 48.44M CNY in the quarter ending March 31, 2026, with 32.08% growth. This brings the company's revenue in the last twelve months to 288.53M, up 71.62% year-over-year. In the year 2025, Hainan Shuangcheng Pharmaceuticals had annual revenue of 276.76M with 58.87% growth.

• Revenue (ttm): 288.53M
• Revenue Growth: +71.62%
• P/S Ratio: 15.16
• Revenue / Employee: 644.03K
• Employees: 605
• Market Cap: 4.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	276.76M	102.56M	58.87%
Dec 31, 2024	174.21M	-61.72M	-26.16%
Dec 31, 2023	235.93M	-38.82M	-14.13%
Jan 1, 2023	274.75M	-45.54M	-14.22%
Jan 1, 2022	320.29M	50.85M	18.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error